ZA200005697B - Paroxetine compositions. - Google Patents

Paroxetine compositions.

Info

Publication number
ZA200005697B
ZA200005697B ZA200005697A ZA200005697A ZA200005697B ZA 200005697 B ZA200005697 B ZA 200005697B ZA 200005697 A ZA200005697 A ZA 200005697A ZA 200005697 A ZA200005697 A ZA 200005697A ZA 200005697 B ZA200005697 B ZA 200005697B
Authority
ZA
South Africa
Prior art keywords
paroxetine compositions
paroxetine
compositions
Prior art date
Application number
ZA200005697A
Inventor
Craig Andrew Simon
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA200005697B publication Critical patent/ZA200005697B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200005697A 1998-03-24 2000-10-16 Paroxetine compositions. ZA200005697B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations

Publications (1)

Publication Number Publication Date
ZA200005697B true ZA200005697B (en) 2001-10-02

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200005697A ZA200005697B (en) 1998-03-24 2000-10-16 Paroxetine compositions.

Country Status (20)

Country Link
EP (1) EP1063993A1 (en)
JP (1) JP2002507569A (en)
CN (1) CN1125639C (en)
AP (1) AP2000001914A0 (en)
AU (1) AU754765B2 (en)
BG (1) BG104865A (en)
BR (1) BR9908991A (en)
CA (1) CA2324612A1 (en)
EA (1) EA003393B1 (en)
GB (1) GB9806312D0 (en)
HU (1) HUP0101326A3 (en)
ID (1) ID26485A (en)
IL (1) IL138478A0 (en)
NO (1) NO313404B1 (en)
NZ (1) NZ506893A (en)
PL (1) PL343095A1 (en)
SK (1) SK14102000A3 (en)
TR (1) TR200002750T2 (en)
WO (1) WO1999048499A1 (en)
ZA (1) ZA200005697B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (en) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Process for the preparation of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
JP5134818B2 (en) * 2003-07-02 2013-01-30 アボット・ラボラトリーズ Method for the manufacture of lipid controlled drug formulations
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (en) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 Paroxetine mesylate capsule and preparation method thereof
CN104027306A (en) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 Paroxetine oral suspension and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3688827T2 (en) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidine derivative, its manufacture and its use as a medicine.
SK283608B6 (en) * 1995-02-06 2003-10-07 Smithkline Beecham Plc New forms of parotexin hydrochloride
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
GB9806312D0 (en) 1998-05-20
BG104865A (en) 2001-05-31
AU3045199A (en) 1999-10-18
EP1063993A1 (en) 2001-01-03
SK14102000A3 (en) 2001-03-12
HUP0101326A2 (en) 2002-05-29
PL343095A1 (en) 2001-07-30
CN1125639C (en) 2003-10-29
NO313404B1 (en) 2002-09-30
EA003393B1 (en) 2003-04-24
CA2324612A1 (en) 1999-09-30
BR9908991A (en) 2000-12-12
AP2000001914A0 (en) 2000-09-30
HUP0101326A3 (en) 2002-06-28
WO1999048499A1 (en) 1999-09-30
NO20004740L (en) 2000-10-03
AU754765B2 (en) 2002-11-21
NZ506893A (en) 2003-06-30
EA200000977A1 (en) 2001-02-26
IL138478A0 (en) 2001-10-31
ID26485A (en) 2001-01-11
CN1294512A (en) 2001-05-09
TR200002750T2 (en) 2000-12-21
NO20004740D0 (en) 2000-09-22
JP2002507569A (en) 2002-03-12

Similar Documents

Publication Publication Date Title
AP2000001874A0 (en) Cellecoxib compositions
GB9917982D0 (en) Compositions
ZA984849B (en) Compositions.
ZA200005478B (en) Shampoo compositions.
GB9811377D0 (en) Compositions
GB9924268D0 (en) Compositions
HK1038884A1 (en) Medicinal compositions.
GB9828861D0 (en) Compositions
ZA200005697B (en) Paroxetine compositions.
GB2339693B (en) Anti-mollusc compositions
ZA200006118B (en) Novel composition.
ZA99890B (en) Pharmaceutical compositions.
GB9905325D0 (en) Compositions
GB9806810D0 (en) Compositions
GB0016470D0 (en) Compositions
GB9812818D0 (en) Dentfrice compositions
GB9827291D0 (en) Compositions
GB2336535B (en) Compositions
ZA200000192B (en) Novel composition.
GB9809347D0 (en) Compositions
GB9827690D0 (en) Compositions
GB9816050D0 (en) Compositions
ZA99925B (en) Composition.
GB9818278D0 (en) Compositions
AU2003200534A1 (en) Paroxetine compositions